Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients NV Conev, IS Donev, AA Konsoulova-Kirova, TG Chervenkov, JK Kashlov, ... Bioscience trends 9 (6), 393-401, 2015 | 46 | 2015 |
Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation … JK Kashlov, IS Donev, JG Doneva, VD Valkov, AD Kirkorova, PI Ghenev, ... Bioscience Trends 10 (4), 294-299, 2016 | 8 | 2016 |
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's … EG Dimitrova, BG Chaushev, NV Conev, JK Kashlov, AK Zlatarov, ... Bioscience trends 11 (2), 221-228, 2017 | 3 | 2017 |
Aвтофагия при солидни тумори 1 Studia Oncologica, 48-56, 2017 | | 2017 |
Beclin-1 като потенциален предиктивен маркер за 5-ФУ базираната химиотерапия при болни с метастатичен карцином на колона | | 2017 |
Dynamic change of NT-PROBNP in patients with ST-elevation myocardial infarction treated with primary coronary intervention JK Kashlov, VD Valkov, YG Doneva, I Donev, A Kirkorova, ... Scripta Scientifica Medica 48 (4), 9-12, 2016 | | 2016 |
Levels of miR-17, miR-21, miR-29a and miR-92 as recurrence markers after adjuvant chemotherapy in Nx lymph node status colon cancer patients NV Conev, A Konsoulova-Kirova, J Kashlov, I Tonev, I Donev Annals of Oncology 27, vi39, 2016 | | 2016 |
FIRST LINE 5-FU-BASED CHEMOTHERAPY WITH/WITHOUT BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: TISSUE BIOMARKER CANDIDATES A Konsoulova, I Donev, N Conev, S Draganova, N Petrova, E Dimitrova, ... Journal of IMAB–Annual Proceeding Scientific Papers 22 (1), 1039-1044, 2016 | | 2016 |
Роля на HMGB1 в патогенезата на миокардния инфаркт, , ЖГ 5) Я. Кашлов, В. Вълков, И. Щерев, Й. Донева, А. Киркорова, Н. Цонев, Л ... НАУКА Кардилогия 4, 175-178, 2016 | | 2016 |
Програмирана некроза и сърдечно-съдови заболявания ЖГ 3) Я. Кашлов, И. Щерев, В. Вълков, Й. Донева, Б. Каназирев НАУКА Кардиология 1, 24-26, 2016 | | 2016 |
First line 5-FU-based chemotherapy with/without bevacizumab for metastatic colorectal cancer: one center experience results A Konsoulova, I Donev, N Conev, S Draganova, T Chervenkov, N Petrova, ... Scripta Scientifica Medica 47, 20-25, 2015 | | 2015 |
Микрорибонуклеинова киселина 208а – биомаркер за диагноза при сърдечно-съдови заболявания СГ Я. Кашлов, И. Щерев, Н. Цонев, Ж. Георгиева НАУКА Кардиология 5, 255-258, 2014 | | 2014 |